Individual Treatments
BPC-157
Injectable, 3mg/mL, 5mL vial
Illustrative packaging. Actual packaging may vary.
A licensed provider reviews your health history and determines whether this treatment is appropriate.
Prescription when appropriate.
Review treatment-specific information with your provider.
Commonly reported effects may include injection-site reactions (redness, discomfort) and nausea. See full safety information ↓
Overview
A provider-reviewed treatment option.
BPC-157 is a prescription formulation for patients focused on recovery and tissue repair. A licensed provider reviews your health history and determines whether treatment is appropriate for you.
Your care journey
A simple, supportive process.
- 1
Complete an online assessment
Share some basic information about your health and goals.
- 2
Provider review
A licensed provider reviews your health history and determines whether treatment is appropriate.
- 3
Ongoing care
If prescribed, you'll have continued support from our care team.
Common questions about BPC-157
Who is a candidate for BPC-157?
A licensed provider reviews your health history and goals. If you meet medical criteria, your provider may prescribe BPC-157 as part of your plan.
How is BPC-157 administered?
As prescribed, typically by injection according to your provider's instructions.
Is BPC-157's compounding status settled?
BPC-157 was removed from FDA Category 2 but has not yet been added to Category 1 — see Important Safety Information for details. Your provider can discuss current status with you.
Related treatments
Molecular profile
- Formula
- C₆₂H₉₈N₁₆O₂₂
- Molecular weight
- 1419.55 g/mol
- CAS number
- 137525-51-0
- Sequence
- Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (15 aa)
Important Safety Information
Compounded BPC-157 is not FDA-approved. Its safety and effectiveness have not been established through large-scale human clinical trials of the compounded formulation, and product strength and quality may vary by compounding pharmacy. Use during pregnancy or breastfeeding, or in patients managing a serious or active medical condition, should be discussed with a provider first.
Reported effects (from available research and clinical reports — not an FDA-established safety profile):
- Injection-site reactions (redness, discomfort)
- Nausea
- Fatigue
- Lightheadedness
BPC-157 was removed from FDA Category 2 (restricted from compounding) but has not yet been added to Category 1 — not on a confirmed legal compounding pathway.
Always use BPC-157 exactly as prescribed, and discuss any questions or side effects with your healthcare provider.